Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet

Study Title
A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet
Teva Identifier
C33237/1099
ClinicalTrials.gov Identifier
NCT01769677
Study Status
Completed
Trial Condition(s)
Pain
Interventions
Drug: 90 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 45-mg tablets (Treatment A) or one 90-mg tablet (Treatment B).

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 45 Years
Trial Duration
01/01/2013 - 02/01/2013
Phase
Phase 1

Study Type

Interventional